The global left atrial appendage closure (LAAC) devices market is projected to register a robust growth from 2025 to 2033.

Global materials science company W. L. Gore & Associates has reached an agreement to acquire Conformal Medical, a medtech ...

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation ...

W.L. Gore & Associates announced today that it agreed to acquire left atrial appendage occlusion (LAAO) device maker ...

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation. Left atrial appendage occlusion (LAAO) placement is associated with a reduced risk for ...

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation The trial met the primary safety ...

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...

FORT MILL, S.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the ...

Catheter Precision, Inc., a US medical device company specializing in cardiac electrophysiology, will attend the 13th International Symposium on Left Atrial Appendage (ISLAA) in Austin, Texas on ...

W. L. Gore & Associates, Inc. (Gore) a global materials science company dedicated to transforming industries and improving ...